Cargando…
Efficacy and utility of a protocol for pre-emptive antimycotic therapy
Autores principales: | Milanov, SG, Georgiev, G, Todorova, V, Kozarov, L, Milanov, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934516/ http://dx.doi.org/10.1186/cc8302 |
Ejemplares similares
-
Empirical versus preemptive antimycotic therapy in terms of outcome benefit
por: Milanov, S, et al.
Publicado: (2013) -
Cardiac-specific troponin I and cardiovascular dysfunction in post-traumatic sepsis
por: Georgiev, G, et al.
Publicado: (2010) -
Sepsis-induced thrombocytopenia: early prediction and modifiable mortality
por: Georgiev, G, et al.
Publicado: (2011) -
Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
por: Todorova, VT, et al.
Publicado: (2013) -
Fungal infections in the intensive care unit? Another approach for defining a target group of patients who benefit from implementing preemptive antimycotic treatment
por: Geube, M, et al.
Publicado: (2007)